Balance Sheet

Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Working Capital Change in Working Capital Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Receivables Refunds Shares Issued Shares Outstanding Shares Outstanding

NovaBridge Biosciences (NBP) Long-Term Debt Repayments (2019 - 2020)

NovaBridge Biosciences (NBP) reported Long-Term Debt Repayments of $15.1 million for Q4 2020, down 33.53% year-over-year from $22.7 million in Q1 2020, and down 33.53% on a QoQ basis from $22.7 million in Q4 2019.

NovaBridge Biosciences (NBP) has 2 years of Long-Term Debt Repayments data on file, last reported at $15.1 million in Q4 2020.

Historic Data

Download Data 🔒

Date	Value
Dec 31, 2020	15.09 Mn
Dec 31, 2020	15.09 Mn
Dec 31, 2019	22.70 Mn
Dec 31, 2019	22.70 Mn